Rubraca logo
  • Ovarian Cancer
  • Important Safety Information
  • Full Prescribing Information
  • Healthcare Professionals
  • Contact Us
  • Ovarian Cancer
  • Important Safety Information
  • Full Prescribing Information
  • Healthcare Professionals
  • Contact Us
  • About Advanced
prostate cancer
    • Importance of Genetic Testing
  • Why RUBRACA
    • How RUBRACA Works
    • HOW RUBRACA CAN HELP
    • Managing Side Effects
  • RESOURCES & SUPPORT
    • Assistance Programs
    • Educational Resources
    • Common Terms
  • For Care Partners
  • About Advanced
prostate cancer
    • Importance of Genetic Testing
  • Why RUBRACA
    • How RUBRACA Works
    • HOW RUBRACA CAN HELP
    • Managing Side Effects
  • RESOURCES & SUPPORT
    • Assistance Programs
    • Educational Resources
    • Common Terms
  • For Care Partners

SITE MAP

  • Home
  • About Advanced Prostate Cancer
    • Importance of Genetic Testing
  • Why RUBRACA
    • How RUBRACA Works
    • How RUBRACA Can Help
    • Managing Side Effects
  • Resources & Support
    • Assistance Programs
    • Educational Resources
    • Common Terms
  • For Care Partners

Other links

  • Ovarian Cancer
  • Important Safety Information
  • Full Prescribing Information
  • HCP Site
  • Contact Us
  • Privacy Policy
  • Site Map
  • Terms & Conditions
  • Tolmar
Tap for safety information

IMPORTANT SAFETY INFORMATION

What is RUBRACA used for?

RUBRACA tablets are a prescription medicine used in adults for:

  • The treatment of castration-resistant prostate cancer (prostate cancer that no longer responds to medical or surgical treatment that lowers testosterone):
    • That has spread to other parts of the body (metastatic), and
    • Has a certain type of inherited (germline) or acquired (somatic) abnormal BRCA gene, and you have been treated with certain medicines for your cancer.
  • Your healthcare provider will perform a test to make sure RUBRACA is right for you.
It is not known if RUBRACA is safe and effective in children.

What Warnings should you know about RUBRACA?

RUBRACA tablets may cause serious side effects including: Bone marrow problems called Myelodysplastic Syndrome (MDS) or a type of cancer of the blood called Acute Myeloid Leukemia (AML). Some people who have cancer and who have received previous treatment with chemotherapy or certain other medicines for their cancer have developed MDS or AML during or after treatment with RUBRACA. MDS or AML may lead to death. If you develop MDS or AML, your healthcare provider will stop treatment with RUBRACA. Symptoms may include weakness, weight loss, fever, frequent infections, blood in urine or stool, shortness of breath, feeling very tired, bruising or bleeding more easily. Symptoms of low blood cell counts are common during treatment with RUBRACA, but can be a sign of serious problems, including MDS or AML.

Before you take RUBRACA, tell your healthcare provider about all of your medical conditions, including if you are a male with a female partner who is pregnant or able to become pregnant, effective birth control should be used during treatment and for 3 months after the last dose of RUBRACA. Do not donate sperm during use and for 3 months after the last dose of RUBRACA. 

What other important information should I know about RUBRACA?

Your healthcare provider will do blood tests before and every month during treatment with RUBRACA to monitor your blood cell counts. Weekly blood tests will be performed if you have low blood cell counts for a long time. Your healthcare provider may stop treatment with RUBRACA until your blood cell counts improve.

Avoid spending time in sunlight while on RUBRACA since your skin may become more sensitive to the sun and may sunburn more easily. You should wear a hat and clothes that cover your skin and use sunscreen to help protect against sunburn if you have to be in the sunlight.

What are the side effects of RUBRACA?

The most common side effects of RUBRACA in people with prostate cancer include: Tiredness or weakness, nausea, decrease in hemoglobin (anemia), changes in liver function tests, decreased appetite, rash, constipation, low blood cell counts, vomiting, and diarrhea. These are not all the possible side effects of RUBRACA. Call your healthcare provider for medical advice about side effects.

What other medications might interact with RUBRACA?

RUBRACA can increase the amounts of other medications you may be taking, which can increase the risk of side effects. Tell your healthcare provider about all your medical conditions and all medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

You may report side effects to the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. You may also report side effects to pharma& at 1-800-506-8501.
This information is not comprehensive.
How to get more information:
  • Talk to your health care provider or pharmacist.
Please see full Prescribing Information for RUBRACA.
Tolmar logo.
The individuals pictured in this site are models, and the images are being used for illustrative
purposes only.
©2024 Tolmar, Inc. All rights reserved. Tolmar, IncreMENtal, ELIGARD, and their associated logos are trademarks of the Tolmar group. Third-party trademarks and product names belong to their respective owners. RUBRACA® is a registered trademark of pharma& Schweiz GmbH, used under license by Tolmar. TPI.2024.eng.4476.v3 12/24
This site is intended for use by US residents only.
  • CORPORATE OFFICES
  • 485 Half Day Road,
    Suite 400
    Buffalo Grove, IL 60089
  • 1-224-880-5770
  • info@tolmar.com
  • PRIVACY POLICY
  • SITE MAP
  • TERMS & CONDITIONS
  • TOLMAR

This site uses cookies, and your privacy is important to us. To accept third-party cookies, click “Accept All Cookies.”

See our Privacy Policy for more details.

  • About Advanced
prostate cancer
    • Importance of Genetic Testing
  • Why RUBRACA
    • How RUBRACA Works
    • HOW RUBRACA CAN HELP
    • Managing Side Effects
  • RESOURCES & SUPPORT
    • Assistance Programs
    • Educational Resources
    • Common Terms
  • For Care Partners
  • Ovarian Cancer
  • Important Safety Information
  • Full Prescribing Information
  • Healthcare Professionals
  • Contact Us

YOU ARE NOW LEAVING RubracaProstate.com

Are you sure you want to leave?

Continue
Cancel and stay
Skip to content
Rubraca
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

3rd Party Cookies

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.

Please enable Strictly Necessary Cookies first so that we can save your preferences!